- Home
- IPXX vs ANIK Comparison
IPXX vs ANIK Comparison
Compare IPXX & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPXX
- ANIK
- Stock Information
- Founded
- IPXX 2023
- ANIK 1983
- Country
- IPXX United States
- ANIK United States
- Employees
- IPXX N/A
- ANIK N/A
- Industry
- IPXX Blank Checks
- ANIK Medical/Dental Instruments
- Sector
- IPXX Finance
- ANIK Health Care
- Exchange
- IPXX Nasdaq
- ANIK Nasdaq
- Market Cap
- IPXX 337.5M
- ANIK 364.2M
- IPO Year
- IPXX 2023
- ANIK 1993
- Fundamental
- Price
- IPXX $10.72
- ANIK $17.43
- Analyst Decision
- IPXX
- ANIK Buy
- Analyst Count
- IPXX 0
- ANIK 2
- Target Price
- IPXX N/A
- ANIK $24.50
- AVG Volume (30 Days)
- IPXX 227.6K
- ANIK 151.8K
- Earning Date
- IPXX 01-01-0001
- ANIK 10-31-2024
- Dividend Yield
- IPXX N/A
- ANIK N/A
- EPS Growth
- IPXX N/A
- ANIK N/A
- EPS
- IPXX 0.37
- ANIK N/A
- Revenue
- IPXX N/A
- ANIK $164,168,000.00
- Revenue This Year
- IPXX N/A
- ANIK N/A
- Revenue Next Year
- IPXX N/A
- ANIK N/A
- P/E Ratio
- IPXX $28.69
- ANIK N/A
- Revenue Growth
- IPXX N/A
- ANIK 0.52
- 52 Week Low
- IPXX $10.27
- ANIK $16.00
- 52 Week High
- IPXX $11.00
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- IPXX 33.79
- ANIK 31.24
- Support Level
- IPXX $10.78
- ANIK $16.70
- Resistance Level
- IPXX $10.81
- ANIK $17.35
- Average True Range (ATR)
- IPXX 0.02
- ANIK 0.73
- MACD
- IPXX -0.01
- ANIK 0.17
- Stochastic Oscillator
- IPXX 12.50
- ANIK 76.00
About IPXX Inflection Point Acquisition Corp. II
Inflection Point Acquisition Corp II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.